News
PPBT
1.730
-1.14%
-0.020
Purple Biotech Updates Investors on CAPTN-3 Platform and Pipeline as IM1240 Nears 2027 Clinic Entry
TipRanks · 2d ago
Weekly Report: what happened at PPBT last week (0615-0619)?
Weekly Report · 3d ago
Weekly Report: what happened at PPBT last week (0608-0612)?
Weekly Report · 06/15 09:50
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 06/11 17:05
Purple Biotech presents new IM1240 data at EACR
TipRanks · 06/11 12:12
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/11 12:05
Purple Biotech Unveils IM1240 Preclinical Data at EACR 2026, Validating CAPTN-3 Immunotherapy Platform
TipRanks · 06/11 11:28
Purple Biotech Presents New Cancer Immunotherapy Data at EACR 2026, Says IM1240 Data Support First Human Study in 2027
Benzinga · 06/11 11:06
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
Barchart · 06/11 06:00
Weekly Report: what happened at PPBT last week (0601-0605)?
Weekly Report · 06/08 09:48
Weekly Report: what happened at PPBT last week (0525-0529)?
Weekly Report · 06/01 09:50
Weekly Report: what happened at PPBT last week (0518-0522)?
Weekly Report · 05/25 09:52
Purple Biotech files $200M mixed securities shelf
TipRanks · 05/20 21:35
PURPLE BIOTECH LTD - BASE PROSPECTUS COVERS OFFERING OF UP TO $200 MLN OF SECURITIES - SEC FILING
Reuters · 05/20 21:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 05/20 17:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 05/20 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 05/19 12:05
Analysts Are Bullish on These Healthcare Stocks: Purple Biotech (PPBT), Satellos Bioscience (MSLE)
TipRanks · 05/18 10:10
Weekly Report: what happened at PPBT last week (0511-0515)?
Weekly Report · 05/18 09:52
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical Momentum
TipRanks · 05/15 11:28
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.